scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Roger A Astley | Q56773909 |
Phillip S Coburn | Q88374661 | ||
P2093 | author name string | Michelle C Callegan | |
Frederick C Miller | |||
Md Huzzatul Mursalin | |||
P2860 | cites work | Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence | Q24598936 |
Alpha-toxin of Staphylococcus aureus | Q24634703 | ||
Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement | Q24646910 | ||
Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks | Q24683675 | ||
Staphylococcus aureus α-toxin: nearly a century of intrigue | Q26823686 | ||
Bacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: host-microbe interactions in intraocular infection | Q26998053 | ||
Role of Staphylococcus aureus Virulence Factors in Inducing Inflammation and Vascular Permeability in a Mouse Model of Bacterial Endophthalmitis | Q27305290 | ||
Staphylococcus aureus infections | Q28131787 | ||
Of mice and not men: differences between mouse and human immunology | Q28246229 | ||
Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia | Q28260215 | ||
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors | Q28304030 | ||
Cataract blindness--challenges for the 21st century | Q28361924 | ||
Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands | Q28493270 | ||
Genetic variation in the Staphylococcus aureus 8325 strain lineage revealed by whole-genome sequencing | Q28533905 | ||
Genomic responses in mouse models poorly mimic human inflammatory diseases | Q29547718 | ||
Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA | Q29617470 | ||
Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury | Q30156106 | ||
Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. | Q30228973 | ||
Bacterial survival amidst an immune onslaught: the contribution of the Staphylococcus aureus leukotoxins. | Q31111609 | ||
Diminished virulence of an alpha-toxin mutant of Staphylococcus aureus in experimental brain abscesses | Q33552970 | ||
Infection by penicillin-resistant staphylococci. | Q54753389 | ||
Panton-Valentine Leucocidin Proves Direct Neuronal Targeting and Its Early Neuronal and Glial Impacts a Rabbit Retinal Explant Model | Q58613254 | ||
Report upon Micro-Organisms in Surgical Diseases | Q58741109 | ||
Disarming Pore-Forming Toxins with Biomimetic Nanosponges in Intraocular Infections | Q64054784 | ||
Molecular epidemiology and resistance profiles among healthcare- and community-associated keratitis isolates | Q64055261 | ||
Involvement of the accessory gene regulator (agr) in expression of type 5 capsular polysaccharide by Staphylococcus aureus | Q72901383 | ||
Impact of the regulatory loci agr, sarA and sae of Staphylococcus aureus on the induction of alpha-toxin during device-related infection resolved by direct quantitative transcript analysis | Q74153291 | ||
Assessment of the role of gamma-toxin in experimental endophthalmitis using a hlg-deficient mutant of Staphylococcus aureus | Q74419789 | ||
Frequency of alpha- and beta-haemolysin in Staphylococcus aureus of bovine and human origin. A comparison between pheno- and genotype and variation in phenotypic expression | Q77407430 | ||
Corneal pathogenesis of Staphylococcus aureus strain Newman | Q77846483 | ||
Isolation and composition of staphylococcal alpha toxin | Q79578677 | ||
EXTRACTION OF A HIGHLY POTENT PENICILLIN INACTIVATOR FROM PENICILLIN RESISTANT STAPHYLOCOCCI | Q81079459 | ||
Distribution of Phage Groups of Staphylococcus aureus in the Years 1927 through 1947 | Q81089842 | ||
Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils | Q81180246 | ||
Age-related differences in rabbits during experimental Staphylococcus aureus keratitis | Q81503653 | ||
Effects of toxin production in a murine model of Staphylococcus aureus keratitis | Q81782011 | ||
Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials | Q83219194 | ||
Staphylococcus aureus alpha-hemolysin impairs corneal epithelial wound healing and promotes intracellular bacterial invasion | Q92043902 | ||
Unexpected absence of meticillin-resistant Staphylococcus aureus nasal carriage by healthcare workers in a tertiary hospital in Kenya. | Q50991840 | ||
Methicillin-resistant Staphylococcus aureus ocular infection: a 10-year hospital-based study. | Q51174715 | ||
Correlation of bacterial colonization status between mother and child: the Generation R Study | Q33704841 | ||
Characterization and persistence of Staphylococcus aureus strains isolated from the anterior nares and throats of healthy carriers in a Mexican community | Q33827200 | ||
Waves of resistance: Staphylococcus aureus in the antibiotic era. | Q33854398 | ||
Global changes in Staphylococcus aureus gene expression in human blood | Q33883340 | ||
Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions | Q33906155 | ||
Clonal associations among Staphylococcus aureus isolates from various sites of infection | Q34005637 | ||
Two cases of corneal ulcer due to methicillin-resistant Staphylococcus aureus in high risk groups | Q34044328 | ||
Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model | Q34154110 | ||
Cross-talk between Staphylococcus aureus leukocidins-intoxicated macrophages and lung epithelial cells triggers chemokine secretion in an inflammasome-dependent manner. | Q34157497 | ||
sigmaB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. | Q34319176 | ||
The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages. | Q34353754 | ||
Staphylococcus aureus β-toxin production is common in strains with the β-toxin gene inactivated by bacteriophage | Q34366631 | ||
Staphylococcus aureus ocular infection: methicillin-resistance, clinical features, and antibiotic susceptibilities | Q34374880 | ||
The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptors | Q34495209 | ||
Toll-like receptor 2 activation depends on lipopeptide shedding by bacterial surfactants | Q34535716 | ||
A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice | Q35332249 | ||
Staphylococcal accessory regulator (sar) in conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis | Q35545994 | ||
Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. | Q35546006 | ||
Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins | Q35558127 | ||
Methicillin-resistant Staphylococcus aureus infections of the eye and orbit (an American Ophthalmological Society thesis). | Q35662677 | ||
Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia | Q35689313 | ||
Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis | Q35782676 | ||
Differential Interaction of the Staphylococcal Toxins Panton-Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors | Q35864500 | ||
Pore-forming protein toxins: from structure to function | Q35961423 | ||
ADAM10 mediates vascular injury induced by Staphylococcus aureus α-hemolysin | Q36083334 | ||
Acute endophthalmitis following cataract surgery: a systematic review of the literature | Q36121591 | ||
Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus | Q36157687 | ||
Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors? | Q36159649 | ||
Phenol-soluble modulins in staphylococci: What are they originally for? | Q36164255 | ||
Carriage ofStaphylococcus aureusamong 104 healthy persons during a 19-month period | Q36504305 | ||
Infectious keratitis: secreted bacterial proteins that mediate corneal damage | Q36567361 | ||
Methicillin-resistant staphylococci | Q36632851 | ||
A biomimetic nanosponge that absorbs pore-forming toxins | Q36828355 | ||
Staphylococcus aureus corneal infections: effect of the Panton-Valentine leukocidin (PVL) and antibody to PVL on virulence and pathology | Q36979233 | ||
Virulence of Staphylococcus aureus in a mouse mastitis model: studies of alpha hemolysin, coagulase, and protein A as possible virulence determinants with protoplast fusion and gene cloning | Q37034077 | ||
Intestinal carriage of Staphylococcus aureus: how does its frequency compare with that of nasal carriage and what is its clinical impact? | Q37238397 | ||
Infectious endophthalmitis after intravitreal injection of antiangiogenic agents | Q37439275 | ||
Intravitreal injection of therapeutic agents | Q37544116 | ||
Innate immunity of the ocular surface | Q37614608 | ||
Staphylococcus aureus toxins | Q37617576 | ||
Complications of intravitreal injections | Q37726939 | ||
Animal models of bacterial keratitis | Q37832951 | ||
Ocular surface inflammation is regulated by innate immunity | Q38021235 | ||
Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). | Q38050249 | ||
Staphylococcus aureus toxins--their functions and genetics | Q38094380 | ||
Staphylococcus aureus: determinants of human carriage | Q38101786 | ||
Formyl-peptide receptor 2 governs leukocyte influx in local Staphylococcus aureus infections | Q38601688 | ||
Pore-forming toxins: ancient, but never really out of fashion | Q38660364 | ||
Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors. | Q38728618 | ||
Modeling intraocular bacterial infections | Q38827899 | ||
Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity | Q39264668 | ||
The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors. | Q39416905 | ||
Channel-forming leucotoxins from Staphylococcus aureus cause severe inflammatory reactions in a rabbit eye model | Q39468385 | ||
Passive immunization with antiserum to a nontoxic alpha-toxin mutant from Staphylococcus aureus is protective in a murine model. | Q39824967 | ||
Selective killing of human monocytes and cytokine release provoked by sphingomyelinase (beta-toxin) of Staphylococcus aureus. | Q39825614 | ||
Toxins of Staphylococcus aureus | Q40254393 | ||
Methicillin-resistant staphylococci | Q41289007 | ||
THE EVOLUTION OF NEW HOSPITAL STRAINS OF STAPHYLOCOCCUS AUREUS. | Q41294452 | ||
The characterization of staphylococcal toxins. I. The electrophoretic migration of the alpha hemolytic, dermonecrotic, lethal, and leucocidal activities of crude toxin | Q42826295 | ||
Mice are not men. | Q43105392 | ||
Association of CD4+ T cell-dependent keratitis with genetic susceptibility to Pseudomonas aeruginosa ocular infection. | Q43495991 | ||
Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers | Q44108639 | ||
Prevalence of genes encoding for members of the staphylococcal leukotoxin family among clinical isolates of Staphylococcus aureus | Q44238861 | ||
Methicillin-resistant Staphylococcus aureus prevalence in community in the east Delhi area. | Q44490076 | ||
Comparative chracterization of Staphylococcus aureus isolates from throats and noses of healthy volunteers. | Q44777628 | ||
Histopathological studies of staphylococcal alpha-toxin: effects on rabbit corneas | Q45170091 | ||
Regulation of Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis | Q46920622 | ||
The Pathogenesis of Staphylococcus aureus Eye Infections | Q47213929 | ||
When Clarity Is Crucial: Regulating Ocular Surface Immunity | Q47297420 | ||
Endophthalmitis after anti-VEGF injections | Q47679278 | ||
Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family | Q48015183 | ||
Panton-Valentine Leukocidin Colocalizes with Retinal Ganglion and Amacrine Cells and Activates Glial Reactions and Microglial Apoptosis | Q49746282 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 6 | |
P921 | main subject | Staphylococcus aureus | Q188121 |
P577 | publication date | 2019-06-19 | |
P1433 | published in | Toxins | Q15724569 |
P1476 | title | An Eye on Staphylococcus aureus Toxins: Roles in Ocular Damage and Inflammation | |
P478 | volume | 11 |
Q89965825 | Bacillus S-Layer-Mediated Innate Interactions During Endophthalmitis |
Q90614457 | Bioguided Purification of Active Compounds from Leaves of Anadenanthera colubrina var. cebil (Griseb.) Altschul |
Q90115200 | Contribution of anti-inflammatory and anti-virulence effects of azithromycin in the treatment of experimental Staphylococcus aureus keratitis |
Q102152320 | Morphological and cytokine profiles as key parameters to distinguish between Gram-negative and Gram-positive bacterial keratitis |
Q101121215 | Recurrent microbial keratitis and endogenous site Staphylococcus aureus colonisation |
Q92422584 | Staphylococcus aureus Toxins: Armaments for a Significant Pathogen |
Q89595741 | The cereus matter of Bacillus endophthalmitis |
Search more.